1SXP — SCHOTT Pharma AG & Co. KGaA Share News
0.000.00%
Last trade - 00:00- €3.71bn
- €3.75bn
- €986.21m
SCHOTT Pharma rises after J.P. Morgan initiates with 'Overweight'
Schott Pharma rises after Barclays upgrades to 'overweight' on accelerating growth outlook
Europe Research Roundup: Adyen, GYM Group, Rolls Royce
Brief: Schott Pharma - Confirms Recently Increased 2026 Financial Year Guidance
SCHOTT Pharma jumps after Q3 revenue beat, guidance hike
Live Markets: Before the bell: Tech leads Europe higher as oil eases
Brief: Schott Pharma Says Expects Q3 2026 Constant-Currency Revenue Growth Of About 8% And Ebitda Margin Of About 27%
SCHOTT Pharma jumps as DB ups to 'buy' on growth prospects
Jefferies cuts Gerresheimer to 'hold' on Bormioli deal risks
Brief: Schott Pharma H1 EBITDA Margin At 26.6%
Barclays flags structural shift to injectables, prefers devices to drug containment
Schott Pharma rises after Q1 sales beat
Brief: SCHOTT Pharma Says Q1 Revenue EUR 240.2 Million
Europe Research Roundup: Flughafen Zuerich, IONOS Group, United Internet
Europe Research Roundup: Allgeier, Heineken, Zehnder Group
Europe Research Roundup: Centrica, IHG, Volvo Car
Brief: Schott Pharma FY EBITDA At EUR 280.3 Mln
BNP picks medtech favourites, sees re-rating in H2 2026
Analysts cut Schott Pharma, expect 2026 to be transition year